Forte Historical Income Statement

FBRX Stock

USD 21.71 1.92 9.70%

Historical analysis of Forte Biosciences income statement accounts such as Interest Expense of 14.5 K or Selling General Administrative of 7.6 M can show how well Forte Biosciences performed in making a profits. Evaluating Forte Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Forte Biosciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Forte Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Forte Biosciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

About Forte Income Statement Analysis

Forte Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Forte Biosciences shareholders. The income statement also shows Forte investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Forte Biosciences Income Statement Chart

At this time, Forte Biosciences' Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1.1 M in 2024, whereas Depreciation And Amortization is likely to drop 8,550 in 2024.

Selling General Administrative Other Operating Expenses Research Development Ebitda Total Operating Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Forte Biosciences. It is also known as Forte Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Forte Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.At this time, Forte Biosciences' Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1.1 M in 2024, whereas Depreciation And Amortization is likely to drop 8,550 in 2024.

	2023	2024 (projected)
Depreciation And Amortization	9K	8.6K
Interest Income	1.1M	1.3M

Depreciation And Amortization Interest Income

Forte Biosciences income statement Correlations

	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Net Income From Continuing Ops	Cost Of Revenue	Reconciled Depreciation	Selling And Marketing Expenses
Interest Income		0.05	0.83	0.2	0.26	0.22	-0.27	-0.13	0.22	-0.13	0.22	-0.1	-0.27	0.02	-0.23	-0.19	0.22	0.06	-0.28	-0.26	0.25
Depreciation And Amortization	0.05		0.1	0.25	0.75	0.81	-0.55	-0.47	0.88	-0.46	0.81	-0.46	-0.68	-0.23	-0.19	0.81	-0.5	0.59	-0.25	-0.13	-0.4
Interest Expense	0.83	0.1		-0.16	0.2	-0.01	0.01	0.2	0.03	0.2	-0.01	0.22	-0.43	0.22	-0.19	-0.05	-0.28	0.35	-0.16	-0.1	-0.22
Selling General Administrative	0.2	0.25	-0.16		0.6	0.72	-0.57	-0.55	0.59	-0.55	0.72	-0.54	-0.08	-0.3	-0.11	-0.19	0.43	-0.25	-0.09	-0.18	0.45
Gross Profit	0.26	0.75	0.2	0.6		0.8	-0.43	-0.49	0.78	-0.48	0.8	-0.48	-0.42	-0.31	-0.01	0.23	-0.13	0.17	-0.09	-0.06	-0.1
Other Operating Expenses	0.22	0.81	-0.01	0.72	0.8		-0.75	-0.7	0.98	-0.69	1.0	-0.69	-0.51	-0.37	-0.21	0.46	-0.01	0.22	-0.23	-0.18	0.1
Operating Income	-0.27	-0.55	0.01	-0.57	-0.43	-0.75		0.27	-0.75	0.26	-0.75	0.24	0.23	-0.19	0.75	-0.45	-0.2	-0.43	0.69	0.65	-0.27
Ebit	-0.13	-0.47	0.2	-0.55	-0.49	-0.7	0.27		-0.69	1.0	-0.7	1.0	0.37	0.89	-0.41	-0.16	-0.19	0.37	-0.3	-0.31	-0.17
Research Development	0.22	0.88	0.03	0.59	0.78	0.98	-0.75	-0.69		-0.68	0.98	-0.67	-0.56	-0.36	-0.23	0.59	-0.1	0.31	-0.26	-0.18	0.01
Ebitda	-0.13	-0.46	0.2	-0.55	-0.48	-0.69	0.26	1.0	-0.68		-0.69	1.0	0.36	0.9	-0.42	-0.15	-0.2	0.38	-0.31	-0.32	-0.18
Total Operating Expenses	0.22	0.81	-0.01	0.72	0.8	1.0	-0.75	-0.7	0.98	-0.69		-0.69	-0.51	-0.37	-0.21	0.46	-0.01	0.22	-0.23	-0.18	0.1
Income Before Tax	-0.1	-0.46	0.22	-0.54	-0.48	-0.69	0.24	1.0	-0.67	1.0	-0.69		0.36	0.91	-0.44	-0.16	-0.18	0.39	-0.33	-0.34	-0.16
Total Other Income Expense Net	-0.27	-0.68	-0.43	-0.08	-0.42	-0.51	0.23	0.37	-0.56	0.36	-0.51	0.36		0.24	0.08	-0.55	0.68	-0.48	-0.05	-0.15	0.63
Net Income	0.02	-0.23	0.22	-0.3	-0.31	-0.37	-0.19	0.89	-0.36	0.9	-0.37	0.91	0.24		-0.78	0.05	-0.11	0.59	-0.63	-0.62	-0.06
Income Tax Expense	-0.23	-0.19	-0.19	-0.11	-0.01	-0.21	0.75	-0.41	-0.23	-0.42	-0.21	-0.44	0.08	-0.78		-0.36	0.0	-0.7	0.84	0.8	-0.08
Tax Provision	-0.19	0.81	-0.05	-0.19	0.23	0.46	-0.45	-0.16	0.59	-0.15	0.46	-0.16	-0.55	0.05	-0.36		-0.59	0.76	-0.4	-0.25	-0.46
Net Interest Income	0.22	-0.5	-0.28	0.43	-0.13	-0.01	-0.2	-0.19	-0.1	-0.2	-0.01	-0.18	0.68	-0.11	0.0	-0.59		-0.66	-0.11	-0.22	0.93
Net Income From Continuing Ops	0.06	0.59	0.35	-0.25	0.17	0.22	-0.43	0.37	0.31	0.38	0.22	0.39	-0.48	0.59	-0.7	0.76	-0.66		-0.65	-0.52	-0.53
Cost Of Revenue	-0.28	-0.25	-0.16	-0.09	-0.09	-0.23	0.69	-0.3	-0.26	-0.31	-0.23	-0.33	-0.05	-0.63	0.84	-0.4	-0.11	-0.65		0.98	-0.21
Reconciled Depreciation	-0.26	-0.13	-0.1	-0.18	-0.06	-0.18	0.65	-0.31	-0.18	-0.32	-0.18	-0.34	-0.15	-0.62	0.8	-0.25	-0.22	-0.52	0.98		-0.31
Selling And Marketing Expenses	0.25	-0.4	-0.22	0.45	-0.1	0.1	-0.27	-0.17	0.01	-0.18	0.1	-0.16	0.63	-0.06	-0.08	-0.46	0.93	-0.53	-0.21	-0.31

Click cells to compare fundamentals

Forte Biosciences Account Relationship Matchups

Forte Biosciences income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Income	1.3M	1.4M	2.3M	162K	1.1M	1.3M
Depreciation And Amortization	11.0K	54K	36K	36.0	9K	8.6K
Interest Expense	3.8M	0.0	222K	17K	15.3K	14.5K
Selling General Administrative	1.4M	4.2M	7.6M	8.3M	10.6M	7.6M
Gross Profit	(11K)	(54K)	(36K)	(9K)	(8.1K)	(7.7K)
Other Operating Expenses	4.1M	14.2M	21.5M	13.9M	32.5M	21.5M
Operating Income	(4.1M)	17.8M	(21.5M)	(13.9M)	(32.5M)	(34.1M)
Ebit	(4.1M)	(46.5M)	(21.5M)	(13.9M)	(32.5M)	(34.1M)
Research Development	2.7M	10.0M	13.9M	5.6M	21.9M	16.1M
Ebitda	(4.1M)	(46.4M)	(21.5M)	(13.9M)	(32.5M)	(34.1M)
Total Operating Expenses	4.1M	14.2M	21.5M	13.9M	32.5M	21.5M
Income Before Tax	(4.1M)	(46.5M)	(21.7M)	(13.9M)	(31.5M)	(33.0M)
Total Other Income Expense Net	(4.3K)	(205K)	(222K)	17K	1.0M	1.1M
Net Income Applicable To Common Shares	(4.1M)	(46.5M)	(21.7M)	(13.9M)	(16.0M)	(16.8M)
Net Income	(4.1M)	(78.5M)	(21.7M)	(13.9M)	(31.5M)	(33.0M)
Income Tax Expense	(2.5K)	32.1M	(200.6K)	(17K)	(19.6K)	(18.6K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Forte Historical Income Statement

About Forte Income Statement Analysis

Forte Biosciences Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Forte Biosciences income statement Correlations

Forte Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Forte Biosciences income statement Accounts

Also Currently Popular

Additional Tools for Forte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Research Development	+ 0.98	Other Operating Expenses
Total Operating Expenses	+ 0.98	Research Development

Income Tax Expense	- 0.78	Net Income
Total Operating Expenses	- 0.75	Operating Income
Research Development	- 0.75	Operating Income
Operating Income	- 0.75	Other Operating Expenses
Net Income From Continuing Ops	- 0.7	Income Tax Expense
Total Operating Expenses	- 0.7	Ebit